Balance Sheet - Apogee Therapeutics, Inc. (APGE)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | |
|---|---|---|---|---|
| Total cash and short-term investments | 730.19 | 520.65 | 395.46 | 151.89 |
| Accounts receivable, net | 4.70 | 1.21 | ||
| Other current assets | 11.17 | 4.36 | 1.74 | 0.17 |
| Total current assets | 741.36 | 529.71 | 398.41 | 152.06 |
| Total non-current assets | 195.78 | 224.24 | 3.00 | 0.00 |
| Total assets | 937.13 | 753.95 | 401.40 | 152.06 |
| Total current liabilities | 27.91 | 28.56 | 20.56 | 9.98 |
| Total non-current liabilities | 5.35 | 8.60 | 0.93 | 0.00 |
| Total liabilities | 33.25 | 37.16 | 21.49 | 9.98 |
| Total stockholders' equity | 903.88 | 716.79 | 379.91 | 142.08 |
| Common shares outstanding | 61 | 55 | 51 | 51 |
Show Quarterly Balance Sheet
Balance Sheet - Apogee Therapeutics, Inc. (APGE)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 1,059.89 | 730.19 | 527.29 | 505.42 | 513.33 | 520.65 | 526.05 | 676.23 | 816.20 | 395.46 | 422.85 | 125.07 | 141.33 | 151.89 | 0.00 | 0.00 | 0.00 |
| Accounts receivable, net | 4.48 | 4.14 | 5.01 | 4.70 | 4.77 | 1.21 | |||||||||||
| Other current assets | 13.91 | 11.17 | 8.33 | 6.57 | 3.19 | 4.36 | 3.66 | 5.63 | 4.41 | 1.74 | 3.57 | 5.60 | 0.69 | 0.17 | |||
| Total current assets | 1,073.80 | 741.36 | 540.10 | 516.12 | 521.53 | 529.71 | 534.48 | 681.85 | 820.61 | 398.41 | 426.42 | 130.67 | 142.02 | 152.06 | |||
| Total non-current assets | 219.86 | 195.78 | 86.06 | 141.65 | 192.63 | 224.24 | 241.80 | 118.80 | 3.05 | 3.00 | 0.20 | 3.47 | 0.00 | 0.00 | |||
| Total assets | 1,293.65 | 937.13 | 626.16 | 657.77 | 714.16 | 753.95 | 776.29 | 800.66 | 823.66 | 401.40 | 426.42 | 130.67 | 142.02 | 152.06 | |||
| Total current liabilities | 32.95 | 27.91 | 34.05 | 31.55 | 32.96 | 28.56 | 32.61 | 24.62 | 21.55 | 20.56 | 17.18 | 17.62 | 11.19 | 9.98 | |||
| Total non-current liabilities | 4.91 | 5.35 | 5.77 | 6.82 | 7.84 | 8.60 | 9.27 | 2.40 | 0.63 | 0.93 | 0.00 | 177.47 | 0.00 | 0.00 | |||
| Total liabilities | 37.86 | 33.25 | 39.82 | 38.37 | 40.80 | 37.16 | 41.88 | 27.02 | 22.18 | 21.49 | 17.18 | 17.62 | 11.19 | 9.98 | |||
| Total stockholders' equity | 1,255.79 | 903.88 | 586.34 | 619.40 | 673.36 | 716.79 | 734.40 | 773.64 | 801.48 | 379.91 | 409.24 | 113.05 | 130.82 | 142.08 | |||
| Common shares outstanding | 70 | 61 | 59 | 58 | 58 | 55 | 57 | 57 | 50 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 |